Approaching Market Access in Europe with Director of Market Development, Europe at Adaptive Biotechnologies.

This is the first in a new CM Life Science series discussing trends and insights into the diagnostics market with industry leaders from across the globe. In this episode, I talk with Delphine Galezowski, Director of Market Development in Europe for Adaptive Biotechnologies.  We discuss European market expansion strategies within the diagnostics space, the differences between European market access and other global territories, and insights from her time leading teams at AstraZeneca. Whether you’re in the diagnostics industry, are intrigued by market access strategies, or are wondering how different organisations and regions differ within the market – then be sure to have a listen. In the following episodes my colleagues will be discussing a range of key trends and insights into key topics within the wider diagnostics market, too. So please subscribe to the series to be notified when their episodes become available. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Life Science's services; then please email me at [email protected].